on Pentixapharm Holding AG (ETR:PTP)
Pentixapharm Holding AG to Reveal 2025 Financial Results
Pentixapharm Holding AG has announced that it will release its financial report for the fiscal year 2025 on March 26, 2026. The biopharmaceutical company, based in Berlin, is set to disclose key insights into its financial performance, operational developments, and strategic objectives during a conference call scheduled for the same day at 10:00 a.m. CET.
CEO Dr. Dirk Pleimes and CBO Henner Kollenberg will lead the presentation. They will provide an overview of the company's progress, particularly in its advanced clinical trials within radiotherapeutics. Additionally, they will highlight future strategic and clinical priorities aimed at enhancing patient care in oncology and cardiology.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Pentixapharm Holding AG news